Resideo Technologies, Inc. REZI 深 滬
已收盤 10-17 16:00:00 美东时间
40.67
-0.740
-1.79%
華盛通- 最 高41.57
- 今 開41.18
- 成交量 92.08万股
- 最 低 40.49
- 昨 收 41.41
- 總市值 60.60亿
- 52周最高 43.96
- 市盈率 靜 66.60
- 換手率 0.62%
- 52周最低 14.18
- 委 比 48.15%
- 總股本 1.49亿
- 歷史最高 43.96
- 量 比 0.77
- 振 幅 2.61%
- 歷史最低 3.72
- 每 手 1
- 風險率 2.17%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cullinan Therapeutics Cancer Drug Shows Efficacy In Brain Metastases Among Lung Cancer Patients With Certain Mutations
Zipalertinib shows 31% intracranial response and good tolerability in CNS-involved EGFR-mutated lung cancer, data presented at ESMO 2025.
10-14 00:46
Cramer Says Arista's 'Doing So Well' — But Snubs Sprouts For Costco
Cramer praises Arista Networks' performance and Needham analyst's positive outlook. Applied Digital loses money, Cramer prefers Costco over Sprouts.
10-01 20:16
美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
09-22 18:44
Oppenheimer Maintains Outperform on Resideo Technologies, Raises Price Target to $48
Oppenheimer analyst Ian Zaffino maintains Resideo Technologies (NYSE:REZI) with a Outperform and raises the price target from $35 to $48.
09-19 21:12
Jim Cramer Recommends Buying This Industrial Stock, Calling It 'Way Too Cheap'
"Mad Money" star Jim Cramer discusses MP Materials, Resideo Technologies and Canadian National Railway on Friday, Sept. 12.
09-12 19:58
Taiho Oncology And Cullinan Therapeutics Report 27% Response Rate In REZILIENT1 And 30% Response Rate In REZILIENT2 Lung Cancer Trial
Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., today announced new data from the REZILIENT1 and REZILIENT2 trials of zipalertinib, an oral EGFR tyrosine kinase inhibitor, in patients with advanced or metastatic
09-09 17:49
Magic Software Stock: Rally Extends, Upside Potential Remains
Magic Software has extended its rally after a major breakout, with bullish momentum intact. Here's what could be next for the stock.
08-14 20:03
Resideo Technologies Stock Signals Bullish Momentum Ahead
Resideo Technologies (NYSE: REZI) has broken out of its Adhishthana Cakra in Phase 9, signaling strong bullish potential with a rally likely to continue into Phase 10.
08-13 23:59
Resideo Technologies Pops As Honeywell Indemnity Buyout Boosts Growth Story
Resideo Technologies (REZI) ended Honeywell indemnification with $1.59B buyout, leading to cleaner earnings, upgraded price forecast of $35 by Morgan Stanley.
08-13 02:07
Resideo Technologies surges as Morgan Stanley upgrades
Resideo Technologies (NYSE:REZI) jumped over 14% during early trading hours on Tuesday as Morgan Stanley upgraded the stock to Overweight from Equaweight. The brokerage firm increased its price targe...
08-12 22:24
